Impact of less invasive axillary staging procedures after neoadjuvant systemic therapy on adjuvant systemic therapy indications in HER2-positive and triple-negative breast cancer. - Claassens EL; Koppert LB; van der Pol CC; Luiten EJT; van Nijnatten TJA; Jager A; de Boer M; van Diest PJ; Smidt ML; Simons JM (European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2026)